19 Nov, 2024 Reasons to be cheerful: 4 takeaways from the BIA UK Life Sciences Regulatory Conference 2024 By Hugo Kent-Egan We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...
05 Nov, 2024 Early Christmas present: MHRA consultation on international recognition of devices By Hugo Kent-Egan The MHRA has provided more information on its plans for rolling-out its new medical device framework. It aims to publish its additional...
07 Oct, 2024 Incoming: MHRA consultation on UK Medical Devices Regulations By Hugo Kent-Egan Alex Denoon On 25 September 2024, the MHRA updated its roll-out of the new medical device regulatory framework for Great Britain. The MHRA aims to...
08 Jul, 2024 Labour's planning reforms for the life sciences sector By Tim Allen Hugo Kent-Egan “To ensure available lab space scales to meet the ambitions of our fast-growing research-intensive industries, not least the life...
01 May, 2024 Highlights from the ABPI Annual Conference 2024 By Hugo Kent-Egan We enjoyed an interesting day hearing about the future of the UK life sciences industry at the ABPI Annual Conference 2024. The...
23 Jun, 2023 Stembryos: Project launched to provide guidance on research using synthetic embryo models By Hugo Kent-Egan This week a project was launched to develop the first governance framework for research involving stem cell-based embryo models (SCBEMs)...
10 Oct, 2022 UK Blood, Tissues and Cells: EU harmonisation in the works By Hugo Kent-Egan In June, the European Commission adopted the proposal for a regulation on standards of quality and safety for substances of human origin...
28 Sep, 2022 Branded medicines: time for a reset? By Hugo Kent-Egan For many years the landscape for the pricing of branded medicines in the UK was stable. This no longer appears to be the case. In recent...